Aprea Therapeutics

Aprea gets 2nd clinical hold in a week, this time for lymphoid malignancy study
Fierce Biotech
Thu, 08/12/21 - 11:20 am
Aprea Therapeutics
FDA
clinical hold
eprenetapopt
lymphoid leukemia
Clinical developments over the holidays
EP Vantage
Mon, 01/4/21 - 10:17 am
Aprea Therapeutics
Arcturus Therapeutics
Axsome Therapeutics
Inovio
Regeneron
clinical trials
oncology
vaccines
COVID-19
After a ‘breakthrough’ beginning to 2020, little Aprea gets crushed by a PhIII failure
Endpoints
Mon, 12/28/20 - 10:50 am
Aprea Therapeutics
eprenetapopt
clinical trials
myelodysplastic syndromes
These 4 Biotechs Have Selling Pressure on the Horizon
Motley Fool
Sun, 03/8/20 - 11:29 pm
IPOs
Frequency Therpeutics
Viela Bio
Aprea Therapeutics
Vir Biotechnology
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Xconomy
Thu, 10/3/19 - 10:08 pm
IPOs
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
ADC Therapeutics
Monopar Therapeutics
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
Sat, 09/28/19 - 04:38 pm
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Aprea Therapeutics Files for $86 Million IPO
CP Wire
Mon, 09/9/19 - 09:58 am
Aprea Therapeutics
myelodysplastic syndromes
IPOs
Aprea Therapeutics Files for $86 Million IPO
Mon, 09/9/19 - 09:33 am
Aprea Therapeutics
myelodysplastic syndromes